1394 related articles for article (PubMed ID: 27980341)
1. Induced pluripotent stem cell technology: a decade of progress.
Shi Y; Inoue H; Wu JC; Yamanaka S
Nat Rev Drug Discov; 2017 Feb; 16(2):115-130. PubMed ID: 27980341
[TBL] [Abstract][Full Text] [Related]
2. Is Human-induced Pluripotent Stem Cell the Best Optimal?
Wang F; Kong J; Cui YY; Liu P; Wen JY
Chin Med J (Engl); 2018 Apr; 131(7):852-856. PubMed ID: 29578130
[TBL] [Abstract][Full Text] [Related]
3. Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications.
Doss MX; Sachinidis A
Cells; 2019 Apr; 8(5):. PubMed ID: 31052294
[TBL] [Abstract][Full Text] [Related]
4. Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders.
Wattanapanitch M
Stem Cells Int; 2019; 2019():5171032. PubMed ID: 31191673
[TBL] [Abstract][Full Text] [Related]
5. [Induced pluripotent stem cell technology and its application in disease research].
Cai CY; Meng FL; Rao L; Liu YY; Zhao XL
Yi Chuan; 2020 Nov; 42(11):1042-1061. PubMed ID: 33229312
[TBL] [Abstract][Full Text] [Related]
6. Induced pluripotent stem cells for regenerative cardiovascular therapies and biomedical discovery.
Nsair A; MacLellan WR
Adv Drug Deliv Rev; 2011 Apr; 63(4-5):324-30. PubMed ID: 21371511
[TBL] [Abstract][Full Text] [Related]
7. Stem Cells: The Game Changers of Human Cardiac Disease Modelling and Regenerative Medicine.
Parrotta EI; Scalise S; Scaramuzzino L; Cuda G
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31744081
[TBL] [Abstract][Full Text] [Related]
8. Large Animal Models for the Clinical Application of Human Induced Pluripotent Stem Cells.
Cong X; Zhang SM; Ellis MW; Luo J
Stem Cells Dev; 2019 Oct; 28(19):1288-1298. PubMed ID: 31359827
[TBL] [Abstract][Full Text] [Related]
9. Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine.
Sayed N; Liu C; Wu JC
J Am Coll Cardiol; 2016 May; 67(18):2161-2176. PubMed ID: 27151349
[TBL] [Abstract][Full Text] [Related]
10. Stem cells: A path towards improved epilepsy therapies.
Lybrand ZR; Goswami S; Hsieh J
Neuropharmacology; 2020 May; 168():107781. PubMed ID: 31539537
[TBL] [Abstract][Full Text] [Related]
11. Recent technological updates and clinical applications of induced pluripotent stem cells.
Diecke S; Jung SM; Lee J; Ju JH
Korean J Intern Med; 2014 Sep; 29(5):547-57. PubMed ID: 25228828
[TBL] [Abstract][Full Text] [Related]
12. Advances in the Generation of Constructed Cardiac Tissue Derived from Induced Pluripotent Stem Cells for Disease Modeling and Therapeutic Discovery.
Roland TJ; Song K
Cells; 2024 Jan; 13(3):. PubMed ID: 38334642
[TBL] [Abstract][Full Text] [Related]
13. iPSC technology-based regenerative therapy for diabetes.
Kondo Y; Toyoda T; Inagaki N; Osafune K
J Diabetes Investig; 2018 Mar; 9(2):234-243. PubMed ID: 28609558
[TBL] [Abstract][Full Text] [Related]
14. Human iPSC banking: barriers and opportunities.
Huang CY; Liu CL; Ting CY; Chiu YT; Cheng YC; Nicholson MW; Hsieh PCH
J Biomed Sci; 2019 Oct; 26(1):87. PubMed ID: 31660969
[TBL] [Abstract][Full Text] [Related]
15. The use of artificial intelligence in induced pluripotent stem cell-based technology over 10-year period: A systematic scoping review.
Vo QD; Saito Y; Ida T; Nakamura K; Yuasa S
PLoS One; 2024; 19(5):e0302537. PubMed ID: 38771829
[TBL] [Abstract][Full Text] [Related]
16. Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications.
Cerneckis J; Cai H; Shi Y
Signal Transduct Target Ther; 2024 Apr; 9(1):112. PubMed ID: 38670977
[TBL] [Abstract][Full Text] [Related]
17. iPSC-Derived Organoids as Therapeutic Models in Regenerative Medicine and Oncology.
Turhan AG; Hwang JW; Chaker D; Tasteyre A; Latsis T; Griscelli F; Desterke C; Bennaceur-Griscelli A
Front Med (Lausanne); 2021; 8():728543. PubMed ID: 34722569
[TBL] [Abstract][Full Text] [Related]
18. Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery.
Qian L; Tcw J
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530458
[TBL] [Abstract][Full Text] [Related]
19. Application of induced pluripotent stem cell technology for the investigation of hematological disorders.
Dolatshad H; Tatwavedi D; Ahmed D; Tegethoff JF; Boultwood J; Pellagatti A
Adv Biol Regul; 2019 Jan; 71():19-33. PubMed ID: 30341008
[TBL] [Abstract][Full Text] [Related]
20. Application Prospect of Induced Pluripotent Stem Cells in Organoids and Cell Therapy.
Zhang T; Qian C; Song M; Tang Y; Zhou Y; Dong G; Shen Q; Chen W; Wang A; Shen S; Zhao Y; Lu Y
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
